3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Conditions
Motor Activity
15
Neoplasms
11
Breast Neoplasms
4
Colonic Neoplasms
3
Colorectal Neoplasms
2
Smoking
1
Sedentary Behavior
1
Recurrence
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Obesity
1
Neoplasm Metastasis
1
Melanoma
1
Lymphedema
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Fractures, Bone
1
Fibrosis
1
Fatigue
1
Death
1
Cardiovascular Diseases
1
Interventions
acalabrutinib
2
Social Determinants of Health
2
Electrocardiography
2
Echocardiography
2
Blood Specimen Collection
2
Aspirin
2
zanubrutinib
1
ribociclib
1
phosphoribosylformylglycinamidine synthetase
1
palbociclib
1
ibrutinib
1
glycidol
1
abemaciclib
1
Vascular Stiffness
1
Testosterone
1
Pulse Wave Analysis
1
Noninvasive Prenatal Testing
1
Magnetic Resonance Spectroscopy
1
Health Services Needs and Demand
1
Gonadotropin-Releasing Hormone
1
Genetic Testing
1
Exercise
1
Eating
1
Diet
1
DNA
1
Chemoradiotherapy
1
Cardiovascular Agents
1
Antineoplastic Agents
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Cardiovascular Diseases
×
Exercise
×
Clear all
NCT03424668
2019-04-16
EPIC-Norfolk
University of Cambridge
Active not recruiting
25,639 enrolled